Although we do not yet have idea biomarkers for RA, progress has been made. We can hope that over the next few years, we will have even better biomarkers to guide our diagnosis and treatment.
You Might Also Like
Explore This IssueJanuary 2015
Also By This Author
Rick Brasington, MD, is a rheumatologist and fellowship program director at Washington University in St. Louis, and an associate editor of The Rheumatologist.